Journal of Stem Cells and Tissue Engineering

Dr. Pradeep Venkatrao Mahajan is a renowned Urosurgeon, Regenerative Medicine Specialist, and Stem Cell Researcher from India. He obtained his MBBS (1983) and MS in General Surgery (1988) from Marathwada University, followed by a Diploma in Urology (1991) from the University of Vienna, Austria. He further enhanced his professional qualifications with an AFIH (Associate Fellow of Industrial Health) from the Central Labour Institute, Government of India (2005) and became a Diplomat of the American Board of Regenerative Medicine (ABRM)—his highest academic and professional credential. After more than three decades as a successful general and urosurgeon, Dr. Mahajan founded StemRx BioScience Solutions Pvt. Ltd. in 2011, a pioneering center in Regenerative Medicine and Cell-Based Therapies. Through StemRx, he has developed innovative, personalized therapeutic protocols using cell-based approaches for over 100 health conditions, aiming to overcome the limitations of conventional medicine. Dr. Mahajan has published over 31 research papers in national and international journals and holds a patent for innovations in the treatment of Avascular Necrosis. His research interests include cell-based therapy, regenerative medicine, stem cell biology, tissue engineering, and translational research. A frequent speaker at global medical conferences across more than 20 countries, he has collaborated with prestigious institutions such as AIIMS (New Delhi), Indiana University (USA), and Ohio State University (USA) on clinical trials using stem cells, exosomes, and tissue nano-transfection technology.

• Stem Cell Biology
• Regenerative Medicine and Cell-Based Therapy
• Reproductive and Infertility Research

1. Pioneer in Regenerative Medicine and Cell-Based Therapies

2. Founder of StemRx BioScience Solutions Pvt. Ltd., focused on translational research in regenerative medicine and personalized cell therapies

3. Faculty & Director – Centre of Excellence for Fellowship Course in Regenerative Medicine (in affiliation with MUHS, Nashik)

4. Collaborations with AIIMS (India), Indiana University (USA), Ohio State University (USA), and Cellex Corporation (Japan) on clinical trials using stem cell and tissue nano-transfection technologies

5. Editorial board member and reviewer for international journals in regenerative medicine, clinical biotechnology, and surgery

6. Speaker at more than 50 international and national conferences, including in France, USA, Japan, UAE, UK, and Nigeria, covering advancements in stem cell science, autism care, and diabetes management

7. Recipient of multiple national and international awards, such as Pioneer in Stem Cells and Regenerative Medicine (2025), Maharashtra Bhushan (2024), Forbes India Recognition (2022), and Asia’s Top Healthcare Award (2016)

1. Preventive Radiology: A Paradigm Shift in Managing Cervical Varices – Int. J. Clinical Obstetrics & Gynecology, 2025

2. Clinical Improvements in Autism Spectrum Disorder with Novel Pulsatile Insulin Therapy – J. Regenerative Medicine & Biology Research, 2025

3. BIONICA-MDI Therapy as Novel Strategy in Complex Diabetic Foot Ulcers – ARC Journal of Diabetes & Endocrinology, 2025

4. A Personalized Integrated Approach to Recurrent Glioblastoma – Indian Journal of Case Reports, 2025

5. Exosomes: Next Generation Medicine – Journal of Advanced Research and Review, 2022

6. Autologous Minimally Invasive Cell-Based Therapy for Meniscal and ACL Regeneration – Hindawi Case Reports in Orthopedics, 2021

7. Management of Type 1 Diabetes Mellitus with Autologous Mesenchymal Stem Cells – CHRISMED Journal of Health & Research, 2019